Piper Sandler Companies reported robust fourth-quarter 2024 earnings, with earnings per share (EPS) of $4.8, surpassing the forecast of $3.93. The company's revenue reached $499 million, exceeding ...
Investor's Business Daily on MSN1h
AbbVie Surges 8% As Immunology Powerhouses Skyrizi And Rinvoq Continue To DominateAbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback